Welcome to kongre.net
Speaker
Associate Professor, Biological Chemistry & Molecular Pharmacology, Dana-Farber Cancer Institute
Sara Buhrlage, Associate Professor, Biological Chemistry & Molecular Pharmacology at Dana-Farber Cancer Institute, spoke at 4th Covalent Drug Discovery & Development Summit (Boston, United States of America, 20–22 Oct 2026) in the session “Expanding Covalent Targeting of Deubiquitinases: Leveraging Novel Warheads to Achieve Selective, In Vivo-Ready Inhibitors”.
20–22 Oct 2026Boston, United States of America
Executive Director, Aclaris Therapeutics
Associate Director, Chemical Biology & Proteomics, Dunad Therapeutics
Core Director, Dana-Farber Cancer Institute
Director, Eli Lilly
Director & Head of Discovery Biology, Frontier Medicines
Co-Founder and Chief Executive Officer, Talus Bio
This profile is built from conference programmes published on kongre.net. It has not been claimed or confirmed by Sara Buhrlage, and it lists only the talks, sessions and presentations named in those programmes.
Is this you? Claim this profile — every request is read by a person before anything is linked.
To ask for a correction or for this profile to be removed, email [email protected].